140 related articles for article (PubMed ID: 15848711)
1. Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transplant Proc; 2005 Mar; 37(2):1326-7. PubMed ID: 15848711
[TBL] [Abstract][Full Text] [Related]
2. Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen.
Andres A; Toso C; Morel P; Demuylder-Mischler S; Bosco D; Baertschiger R; Pernin N; Bucher P; Majno PE; Bühler LH; Berney T
Transpl Int; 2005 Nov; 18(11):1226-30. PubMed ID: 16221151
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
[TBL] [Abstract][Full Text] [Related]
4. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
5. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
[TBL] [Abstract][Full Text] [Related]
6. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
[No Abstract] [Full Text] [Related]
7. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
8. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
9. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
11. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
[TBL] [Abstract][Full Text] [Related]
12. Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus.
Morales JM; Grinyó JM; Campistol JM; García-Martínez J; Arias M; Paul J; Sánchez-Fructuoso A; Brunet M; Granados E; Munoz-Robles JA
Transplantation; 2008 Aug; 86(4):620-2. PubMed ID: 18724234
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
[TBL] [Abstract][Full Text] [Related]
14. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
15. Initial single-center experience with sirolimus after lung transplantation.
Lischke R; Simonek J; Matousovic K; Stolz AJ; Schützner J; Vojácek J; Burkert J; Davidová R; Pafko P
Transplant Proc; 2006 Nov; 38(9):3006-11. PubMed ID: 17112886
[TBL] [Abstract][Full Text] [Related]
16. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression for pancreatic islet transplantation.
Berney T; Buhler LH; Majno P; Mentha G; Morel P
Transplant Proc; 2004 Mar; 36(2 Suppl):362S-366S. PubMed ID: 15041369
[TBL] [Abstract][Full Text] [Related]
19. Successful islet transplantation from the pancreata of non-heart-beating donors.
Kenmochi T; Maruyama M; Saigo K; Akutsu N; Iwashita C; Otsuki K; Ito T; Suzuki A; Miyazaki M; Saito T
Transplant Proc; 2008 Oct; 40(8):2568-70. PubMed ID: 18929803
[TBL] [Abstract][Full Text] [Related]
20. Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device.
Marzorati S; Bocca N; Molano RD; Hogan AR; Doni M; Cobianchi L; Inverardi L; Ricordi C; Pileggi A
Transplant Proc; 2009; 41(1):352-3. PubMed ID: 19249555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
